The regenerative medicine market is estimated to be valued at US$19.322 billion in 2020.
Regenerative treatments or medicines work inside to repair damaged bodily tissues or organs. These medications fix the injured body organs that would otherwise be unable to mend naturally—a process known as rejuvenation. Regenerative medicines can also be used to replace damaged cells, tissues, or organs by using healthy cells, tissues, or organs from a deceased or healthy donor. The second method of using these medications to repair damaged tissue involves transferring healthy cells or tissues to sick or injured cells in order to maintain the body's regular functioning, a process known as regeneration.
Increasing rates of hereditary disorders and chronic diseases to boost the market
The demand for cell therapy in the regenerative medicine industry is rising due to the rise in disorders including Duchenne muscular dystrophy (DMD), Parkinson's disease, congestive heart failure, and myocardial infarction. Additionally, the market expansion is driven by the use of heterotopic autologous grafts, such as intestine, colon, or stomach, for the reconstruction of the bladder, ureter, and urethra. Many businesses are working with other businesses or research institutions in an effort to advance cell therapy. Government funding for regenerative medicine research is expected to increase, which is one of the main factors driving market expansion. Additionally, a rising pipeline of regenerative medicine treatments and an increase in product approvals will further fuel market expansion potential in the years to come.
Geographically, the Regenerative medicines market is segmented as North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The greatest market share corresponds to the North American region owing to the expansion of the healthcare sector and the rising adoption of stem cell therapy.
|Market Size Value in 2020||US$19.322 billion|
|Growth Rate||CAGR during the forecast period|
|Forecast Unit (Value)||USD Billion|
|Segments Covered||Type, Application, End User, And Geography|
|Regions Covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies Covered||Novartis, Amgen, Bluebird Bio, GSK plc., Shenzhen Sibiono Genetech, Anterogen CO., LTD., Chiesi Farmaceutici S.p.a., Jcr Pharmaceuticals, Nipro|
|Customization Scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What is the size of the global regenerative medicine market?
A1. Regenerative Medicine Market was valued at US$19.322 billion in 2020.
Q2. Who are the major players in the regenerative medicine market?
A2. Prominent key market players in the regenerative medicine market include Novartis, Amgen, Bluebird Bio, GSK plc., Shenzhen Sibiono Genetech, and Anterogen CO., LTD., among others.
Q3. How is the regenerative medicine market segmented?
A3. The global regenerative medicine market has been segmented by type, application, end-user, and geography.
Q4. What factors are anticipated to drive the regenerative medicine market growth?
A4. Increasing rates of hereditary disorders and chronic diseases are major factors to boost the regenerative medicine market growth.
Q5. Which region holds the largest share of the regenerative medicine market?
A5. North America holds the largest share of the regenerative medicine market owing to the expansion of the healthcare sector and the rising adoption of stem cell therapy.
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. GLOBAL REGENERATIVE MEDICINE MARKET ANALYSIS, BY TYPE
5.2. Stem Cell Therapy
5.3. Tissue Engineering
5.4. Small Molecules & Biologics
6. GLOBAL REGENERATIVE MEDICINE MARKET ANALYSIS, BY APPLICATION
7. GLOBAL REGENERATIVE MEDICINE MARKET ANALYSIS, BY END-USER
7.2. Biomedical Laboratories
7.3. Research centers
8. GLOBAL REGENERATIVE MEDICINE MARKET ANALYSIS, BY GEOGRAPHY
8.2. North America
8.3. South America
8.4.3. United Kingdom
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.6. Asia Pacific
8.6.4. South Korea
9. COMPETITIVE INTELLIGENCE
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.3. Bluebird Bio
10.4. GSK plc.
10.5. Sibiono Genetech
10.6. Anterogen Co. Limited
10.7. Chiesi Farmaceutici S.p.a.
10.8. Jcr Pharmaceuticals
Shenzhen Sibiono Genetech
Anterogen CO., LTD.
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.